CDI invited to exhibit at first White House "Demo Day" - Today 2PM
Large_CDI_Logo
 
FOR IMMEDIATE RELEASE
CDI Laboratories Invited to Participate in the First "Demo Day" Hosted by President Obama at the White House
Proteomics Leader to Display its HuProt™ Human Proteome Microarray
MAYAGUEZ, PR and BALTIMORE, MD -- AUGUST 4, 2015

CDI Laboratories ("CDl"), developer of the world's largest collection of recombinant human proteins (19,394) "printed" on a single microscope slide, will take part in  "Demo Day" at the White House today, August 4th. CDI founder and CEO Dr Ignacio Pino will join a select group of entrepreneurs that will present their companies at the event, hear remarks from the President, and interact with other company founders, leaders of industry, high-level senior government officials, private sector representatives, and others.

Dr. Pino commented, "We are honored and excited to participate in this event. CDI offers over 75% of the human proteome to academic and industrial scientists as a unique, convenient and rapid assay platform. It's proving to be a powerful tool in understanding disease processes and can speed the development of potential therapeutics. It is also becoming a game-changer for assessing the quality of research antibodies, currently a $1.5 billion market in the life sciences sector." 
 
For more information visit www.whitehouse.gov/demo-day

The event will be webcast live from the East Room of the White House:  www.whitehouse.gov/live and can be followed on Twitter: #WHDemoDay.


Time approximate:  TODAY  2:00 - 4:00 PM.

About CDI Laboratories

CDI HuProt™ protein microarrays and related discovery services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.

The Company's microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.

CDI has patents in process for technologies to increase high throughput analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers.

The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.

For more information, visit www.cdi-lab.com.



© Copyright 2015   CDI Laboratories Inc.  All rights reserved.

#  #  #

 




Click to view this email in a browser

If you no longer wish to receive these emails, please reply to this message with "Unsubscribe" in the subject line or simply click on the following link: Unsubscribe

CDI Laboratories
65 Old Military Rd
Lake Placid, NY 12983
US

Read the VerticalResponse marketing policy.

Try Email Marketing with VerticalResponse!